Medicare Rx Spending Means No Let Up In Off-Label Use Investigations, Attorney Predicts
This article was originally published in The Pink Sheet Daily
Executive Summary
The federal government will seek to curb off-label use further as it becomes responsible for 45% of total drug spending under the new Medicare law, Morgan Lewis' Mahinka says.